Skip to main content

Table 3 Subgroup analysis stratified by pathological type

From: Associations of DNMT3B −149C>T and −2437T>A polymorphisms and lung cancer risk in Chinese population

Genotype

Pathological type

 

SCC

ORa (95%CI)

AC

ORa (95%CI)

ASC

ORa (95%CI)

SCLC

ORa (95%CI)

−149C>T

TT

19 (8.5)

0.54 (0.31 1.56)

15 (5.8)

0.23 (0.33 2.01)

6 (9.8)

0.17 (0.54 1.98)

7 (4.8)

0.24 (0.31 2.12)

CT

63 (28.7)

0.76 (0.25 1.81)

81 (31.7)

0.81 (0.77 1.67)

22 (34.1)

0.42 (0.34 1.63)

37 (25.8)

0.58 (0.22 1.37)

CC

139 (62.8)

Reference

161 (62.5)

Reference

36 (56.1)

Reference

99 (69.4)

Reference

CT+TT

82 (37.2)

0.82 (0.53 1.27)

96 (37.5)

0.90 (0.59 1.39)

68 (.43.9)

0.55 (0.26 1.15)

44 (30.6)

0.63 (0.35 1.44)

−2437T>A

AA

31 (14.0)

0.57 (1.21 2.14)

11 (4.2)

0.45 (0.72 1.51)

6 (9.8)

0.26 (1.32 2.31)

14 (9.7)

0.37 (0.87 1.92)

TA

79 (35.6)

0.85 (0.58 1.67)

122 (47.5)

0.89 (0.22 1.21)

22 (34.1)

0.76 (0.28 1.64)

55 (38.7)

0.88 (0.64 1.55)

TT

111 (50.4)

Reference

124 (48.3)

Reference

36 (56.1)

Reference

73 (51.6)

Reference

TA+AA

110 (49.6)

0.99 (0.65 1.52)

133 (51.7)

1.08 (0.71 1.64)

68 (43.9)

0.83 (0.43 1.61)

69 (48.4)

0.95 (0.56 1.64)

  1. SCC squamous cell carcinoma, AC adenomatous carcinoma, ASC adenosquamous carcinomas, SCLC small cell lung cancer, TNM tumor-node-metastasis, OR odds ratio, CI confidence interval
  2. aAdjusted for age and sex in a logistic regression model